(1)要約四半期連結財政状態計算書
|
(単位:百万円)
|
|
|
|
前連結会計年度 (2025年3月31日)
|
|
当第1四半期連結会計期間 (2025年6月30日)
|
|
資産
|
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び現金同等物
|
|
209,838
|
|
142,561
|
|
営業債権及びその他の債権
|
|
593,836
|
|
538,949
|
|
その他の金融資産
|
|
45,015
|
|
60,091
|
|
棚卸資産
|
|
625,243
|
|
646,530
|
|
その他の流動資産
|
|
49,993
|
|
63,330
|
|
小計
|
|
1,523,925
|
|
1,451,461
|
|
売却目的で保有する資産
|
|
59,209
|
|
49,028
|
|
流動資産合計
|
|
1,583,134
|
|
1,500,489
|
|
非流動資産
|
|
|
|
|
|
有形固定資産
|
|
759,266
|
|
755,865
|
|
のれん
|
|
257,811
|
|
250,508
|
|
無形資産
|
|
239,319
|
|
229,581
|
|
持分法で会計処理されている 投資
|
|
287,977
|
|
273,510
|
|
その他の金融資産
|
|
177,405
|
|
184,162
|
|
退職給付に係る資産
|
|
72,618
|
|
73,331
|
|
繰延税金資産
|
|
34,608
|
|
36,854
|
|
その他の非流動資産
|
|
27,646
|
|
25,249
|
|
非流動資産合計
|
|
1,856,650
|
|
1,829,060
|
|
資産合計
|
|
3,439,784
|
|
3,329,549
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
前連結会計年度 (2025年3月31日)
|
|
当第1四半期連結会計期間 (2025年6月30日)
|
|
負債及び資本
|
|
|
|
|
|
負債
|
|
|
|
|
|
流動負債
|
|
|
|
|
|
社債及び借入金
|
|
252,892
|
|
218,033
|
|
営業債務及びその他の債務
|
|
488,132
|
|
479,168
|
|
その他の金融負債
|
|
81,364
|
|
73,018
|
|
未払法人所得税等
|
|
10,627
|
|
7,201
|
|
引当金
|
|
89,711
|
|
85,885
|
|
その他の流動負債
|
|
109,360
|
|
88,366
|
|
小計
|
|
1,032,086
|
|
951,671
|
|
売却目的で保有する資産に 直接関連する負債
|
|
6,661
|
|
8,508
|
|
流動負債合計
|
|
1,038,747
|
|
960,179
|
|
非流動負債
|
|
|
|
|
|
社債及び借入金
|
|
1,033,236
|
|
1,030,074
|
|
その他の金融負債
|
|
91,157
|
|
87,900
|
|
退職給付に係る負債
|
|
24,841
|
|
23,884
|
|
引当金
|
|
25,974
|
|
27,703
|
|
繰延税金負債
|
|
111,048
|
|
107,199
|
|
その他の非流動負債
|
|
40,366
|
|
31,220
|
|
非流動負債合計
|
|
1,326,622
|
|
1,307,980
|
|
負債合計
|
|
2,365,369
|
|
2,268,159
|
|
資本
|
|
|
|
|
|
資本金
|
|
90,059
|
|
90,059
|
|
利益剰余金
|
|
640,611
|
|
628,066
|
|
自己株式
|
|
△8,361
|
|
△8,361
|
|
その他の資本の構成要素
|
|
174,871
|
|
173,299
|
|
売却目的で保有する資産に関連する その他の包括利益
|
|
3,610
|
|
2,802
|
|
親会社の所有者に帰属する持分 合計
|
|
900,790
|
|
885,865
|
|
非支配持分
|
|
173,625
|
|
175,525
|
|
資本合計
|
|
1,074,415
|
|
1,061,390
|
|
負債及び資本合計
|
|
3,439,784
|
|
3,329,549
|
|
|
|
|
|
|
E00752
40050
住友化学株式会社
SUMITOMO CHEMICAL COMPANY, LIMITED
四半期第3号参考様式 [IFRS](連結)
IFRS
true
cte
2025-04-01
2025-06-30
Q1
2026-03-31
2024-04-01
2024-06-30
2025-03-31
1
false
false
false
40050
2025-08-01
40050
2025-06-30
40050
2025-06-30
jpigp_cor:CapitalSurplusIFRSMember
40050
2025-06-30
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2025-06-30
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2025-06-30
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2025-06-30
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2025-06-30
jpigp_cor:NonControllingInterestsIFRSMember
40050
2025-06-30
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2025-06-30
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2025-06-30
jpigp_cor:RetainedEarningsIFRSMember
40050
2025-06-30
jpigp_cor:ShareCapitalIFRSMember
40050
2025-06-30
jpigp_cor:TreasurySharesIFRSMember
40050
2025-06-30
tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2025-04-01
2025-06-30
40050
2025-04-01
2025-06-30
jpigp_cor:CapitalSurplusIFRSMember
40050
2025-04-01
2025-06-30
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2025-04-01
2025-06-30
jpcrp_cor:EntityTotalMember
40050
2025-04-01
2025-06-30
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2025-04-01
2025-06-30
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2025-04-01
2025-06-30
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2025-04-01
2025-06-30
jpigp_cor:NonControllingInterestsIFRSMember
40050
2025-04-01
2025-06-30
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
40050
2025-04-01
2025-06-30
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2025-04-01
2025-06-30
jpcrp_cor:ReconcilingItemsMember
40050
2025-04-01
2025-06-30
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2025-04-01
2025-06-30
jpcrp_cor:ReportableSegmentsMember
40050
2025-04-01
2025-06-30
jpigp_cor:RetainedEarningsIFRSMember
40050
2025-04-01
2025-06-30
jpigp_cor:ShareCapitalIFRSMember
40050
2025-04-01
2025-06-30
jpigp_cor:TreasurySharesIFRSMember
40050
2025-04-01
2025-06-30
tse-qcediffr-40050:AdvancedMedicalSolutionsReportableSegmentMember
40050
2025-04-01
2025-06-30
tse-qcediffr-40050:AgroAndLifeSolutionsReportableSegmentMember
40050
2025-04-01
2025-06-30
tse-qcediffr-40050:EssentialAndGreenMaterialsReportableSegmentMember
40050
2025-04-01
2025-06-30
tse-qcediffr-40050:ICTAndMobilitySolutionsReportableSegmentMember
40050
2025-04-01
2025-06-30
tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2025-04-01
2025-06-30
tse-qcediffr-40050:SumitomoPharmaReportableSegmentMember
40050
2024-06-30
40050
2024-06-30
jpigp_cor:CapitalSurplusIFRSMember
40050
2024-06-30
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2024-06-30
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2024-06-30
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2024-06-30
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2024-06-30
jpigp_cor:NonControllingInterestsIFRSMember
40050
2024-06-30
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2024-06-30
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2024-06-30
jpigp_cor:RetainedEarningsIFRSMember
40050
2024-06-30
jpigp_cor:ShareCapitalIFRSMember
40050
2024-06-30
jpigp_cor:TreasurySharesIFRSMember
40050
2024-06-30
tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2025-03-31
40050
2025-03-31
jpigp_cor:CapitalSurplusIFRSMember
40050
2025-03-31
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2025-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2025-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2025-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2025-03-31
jpigp_cor:NonControllingInterestsIFRSMember
40050
2025-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2025-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2025-03-31
jpigp_cor:RetainedEarningsIFRSMember
40050
2025-03-31
jpigp_cor:ShareCapitalIFRSMember
40050
2025-03-31
jpigp_cor:TreasurySharesIFRSMember
40050
2025-03-31
tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2024-04-01
2024-06-30
40050
2024-04-01
2024-06-30
jpigp_cor:CapitalSurplusIFRSMember
40050
2024-04-01
2024-06-30
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2024-04-01
2024-06-30
jpcrp_cor:EntityTotalMember
40050
2024-04-01
2024-06-30
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2024-04-01
2024-06-30
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2024-04-01
2024-06-30
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2024-04-01
2024-06-30
jpigp_cor:NonControllingInterestsIFRSMember
40050
2024-04-01
2024-06-30
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
40050
2024-04-01
2024-06-30
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2024-04-01
2024-06-30
jpcrp_cor:ReconcilingItemsMember
40050
2024-04-01
2024-06-30
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2024-04-01
2024-06-30
jpcrp_cor:ReportableSegmentsMember
40050
2024-04-01
2024-06-30
jpigp_cor:RetainedEarningsIFRSMember
40050
2024-04-01
2024-06-30
jpigp_cor:ShareCapitalIFRSMember
40050
2024-04-01
2024-06-30
jpigp_cor:TreasurySharesIFRSMember
40050
2024-04-01
2024-06-30
tse-qcediffr-40050:AdvancedMedicalSolutionsReportableSegmentMember
40050
2024-04-01
2024-06-30
tse-qcediffr-40050:AgroAndLifeSolutionsReportableSegmentMember
40050
2024-04-01
2024-06-30
tse-qcediffr-40050:EssentialAndGreenMaterialsReportableSegmentMember
40050
2024-04-01
2024-06-30
tse-qcediffr-40050:ICTAndMobilitySolutionsReportableSegmentMember
40050
2024-04-01
2024-06-30
tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2024-04-01
2024-06-30
tse-qcediffr-40050:SumitomoPharmaReportableSegmentMember
40050
2024-03-31
40050
2024-03-31
jpigp_cor:CapitalSurplusIFRSMember
40050
2024-03-31
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2024-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2024-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2024-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2024-03-31
jpigp_cor:NonControllingInterestsIFRSMember
40050
2024-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2024-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2024-03-31
jpigp_cor:RetainedEarningsIFRSMember
40050
2024-03-31
jpigp_cor:ShareCapitalIFRSMember
40050
2024-03-31
jpigp_cor:TreasurySharesIFRSMember
40050
2024-03-31
tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
iso4217:JPY
iso4217:JPY
xbrli:shares
xbrli:pure